Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 28 06 2019
accepted: 03 12 2019
entrez: 3 3 2020
pubmed: 3 3 2020
medline: 28 5 2020
Statut: epublish

Résumé

Systematic collection of mortality/morbidity data over time is crucial for monitoring trends in population health, developing health policies, assessing the impact of health programs. In Poland, a comprehensive analysis describing trends in disease burden for major conditions has never been published. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides data on the burden of over 300 diseases in 195 countries since 1990. We used the GBD database to undertake an assessment of disease burden in Poland, evaluate changes in population health between 1990-2017, and compare Poland with other Central European (CE) countries. The results of GBD 2017 for 1990 and 2017 for Poland and CE were used to assess rates and trends in years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs). Data came from cause-of-death registration systems, population health surveys, disease registries, hospitalization databases, and the scientific literature. Analytical approaches have been used to adjust for missing data, errors in cause-of-death certification, and differences in data collection methodology. Main estimation strategies were ensemble modelling for mortality and Bayesian meta-regression for disability. Between 1990-2017, age-standardized YLL rates for all causes declined in Poland by 46.0% (95% UI: 43.7-48.2), YLD rates declined by 4.0% (4.2-4.9), DALY rates by 31.7% (29.2-34.4). For both YLLs and YLDs, greater relative declines were observed for females. There was a large decrease in communicable, maternal, neonatal, and nutritional disease DALYs (48.2%; 46.3-50.4). DALYs due to non-communicable diseases (NCDs) decreased slightly (2.0%; 0.1-4.6). In 2017, Poland performed better than CE as a whole (ranked fourth for YLLs, sixth for YLDs, and fifth for DALYs) and achieved greater reductions in YLLs and DALYs than most CE countries. In 2017 and 1990, the leading cause of YLLs and DALYs in Poland and CE was ischaemic heart disease (IHD), and the leading cause of YLDs was low back pain. In 2017, the top 20 causes of YLLs and YLDs in Poland and CE were the same, although in different order. In Poland, age-standardized DALYs from neonatal causes, other cardiovascular and circulatory diseases, and road injuries declined substantially between 1990-2017, while alcohol use disorders and chronic liver diseases increased. The highest observed-to-expected ratios were seen for alcohol use disorders for YLLs, neonatal sepsis for YLDs, and falls for DALYs (3.21, 2.65, and 2.03, respectively). There was relatively little geographical variation in premature death and disability in CE in 2017, although some between-country differences existed. Health in Poland has been improving since 1990; in 2017 Poland outperformed CE as a whole for YLLs, YLDs, and DALYs. While the health gap between Poland and Western Europe has diminished, it remains substantial. The shift to NCDs and chronic disability, together with marked between-gender health inequalities, poses a challenge for the Polish health-care system. IHD is still the leading cause of disease burden in Poland, but DALYs from IHD are declining. To further reduce disease burden, an integrated response focused on NCDs and population groups with disproportionally high burden is needed.

Sections du résumé

BACKGROUND
Systematic collection of mortality/morbidity data over time is crucial for monitoring trends in population health, developing health policies, assessing the impact of health programs. In Poland, a comprehensive analysis describing trends in disease burden for major conditions has never been published. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides data on the burden of over 300 diseases in 195 countries since 1990. We used the GBD database to undertake an assessment of disease burden in Poland, evaluate changes in population health between 1990-2017, and compare Poland with other Central European (CE) countries.
METHODS
The results of GBD 2017 for 1990 and 2017 for Poland and CE were used to assess rates and trends in years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs). Data came from cause-of-death registration systems, population health surveys, disease registries, hospitalization databases, and the scientific literature. Analytical approaches have been used to adjust for missing data, errors in cause-of-death certification, and differences in data collection methodology. Main estimation strategies were ensemble modelling for mortality and Bayesian meta-regression for disability.
RESULTS
Between 1990-2017, age-standardized YLL rates for all causes declined in Poland by 46.0% (95% UI: 43.7-48.2), YLD rates declined by 4.0% (4.2-4.9), DALY rates by 31.7% (29.2-34.4). For both YLLs and YLDs, greater relative declines were observed for females. There was a large decrease in communicable, maternal, neonatal, and nutritional disease DALYs (48.2%; 46.3-50.4). DALYs due to non-communicable diseases (NCDs) decreased slightly (2.0%; 0.1-4.6). In 2017, Poland performed better than CE as a whole (ranked fourth for YLLs, sixth for YLDs, and fifth for DALYs) and achieved greater reductions in YLLs and DALYs than most CE countries. In 2017 and 1990, the leading cause of YLLs and DALYs in Poland and CE was ischaemic heart disease (IHD), and the leading cause of YLDs was low back pain. In 2017, the top 20 causes of YLLs and YLDs in Poland and CE were the same, although in different order. In Poland, age-standardized DALYs from neonatal causes, other cardiovascular and circulatory diseases, and road injuries declined substantially between 1990-2017, while alcohol use disorders and chronic liver diseases increased. The highest observed-to-expected ratios were seen for alcohol use disorders for YLLs, neonatal sepsis for YLDs, and falls for DALYs (3.21, 2.65, and 2.03, respectively).
CONCLUSIONS
There was relatively little geographical variation in premature death and disability in CE in 2017, although some between-country differences existed. Health in Poland has been improving since 1990; in 2017 Poland outperformed CE as a whole for YLLs, YLDs, and DALYs. While the health gap between Poland and Western Europe has diminished, it remains substantial. The shift to NCDs and chronic disability, together with marked between-gender health inequalities, poses a challenge for the Polish health-care system. IHD is still the leading cause of disease burden in Poland, but DALYs from IHD are declining. To further reduce disease burden, an integrated response focused on NCDs and population groups with disproportionally high burden is needed.

Identifiants

pubmed: 32119685
doi: 10.1371/journal.pone.0226766
pii: PONE-D-19-18426
pmc: PMC7051048
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0226766

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet. 2013 Jun 8;381(9882):1987-2015
pubmed: 23746901
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Lancet. 2015 Dec 5;386(10010):2257-74
pubmed: 26382241
Health Place. 2017 Sep;47:44-53
pubmed: 28738213
Dev Period Med. 2017;21(2):104-110
pubmed: 28796981
BMC Public Health. 2012 Jun 08;12:311
pubmed: 22537389
BMJ. 2012 Jan 25;344:d8136
pubmed: 22279114
Br Med Bull. 2017 Jan 1;121(1):47-60
pubmed: 28069615
Lancet Public Health. 2018 Aug;3(8):e395-e406
pubmed: 30055996
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Scand J Work Environ Health. 2017 Nov 1;43(6):526-539
pubmed: 28945263
Lancet. 2016 Oct 8;388(10053):1447
pubmed: 27733277
Ann Agric Environ Med. 2018 Mar 14;25(1):124-130
pubmed: 29575863
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
JAMA Cardiol. 2016 Aug 1;1(5):594-9
pubmed: 27438477
Arch Public Health. 2017 Sep 18;75:40
pubmed: 28936356
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Eur J Public Health. 2014 Aug;24(4):673-9
pubmed: 23794676
BMJ. 2018 Jan 31;360:k96
pubmed: 29386181
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):34-45
pubmed: 28658371
BMC Public Health. 2017 Feb 15;17(1):198
pubmed: 28202029
Am J Prev Med. 2014 Mar;46(3 Suppl 1):S1-6
pubmed: 24512925
Pain Res Manag. 2018 Oct 1;2018:4696180
pubmed: 30364097
Circulation. 2000 Sep 26;102(13):1511-6
pubmed: 11004141
Alcohol Clin Exp Res. 2014 Apr;38(4):1068-77
pubmed: 24428196
Lancet. 2012 Dec 15;380(9859):2063-6
pubmed: 23245602
J Gerontol A Biol Sci Med Sci. 2016 Aug;71(8):1063-8
pubmed: 26748094
Depress Anxiety. 2009;26(12):1062-5
pubmed: 19957277
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875
Hum Resour Health. 2016 Jun 30;14(Suppl 1):24
pubmed: 27380776

Auteurs

Maria Gańczak (M)

Department of Infectious Diseases, Institute of Medical Sciences, Zielona Góra University, Zielona Góra, Poland.

Tomasz Miazgowski (T)

Department of Propedeutics of Internal Diseases, Pomeranian Medical University, Szczecin, Poland.

Marta Kożybska (M)

Department of Medical Law of the Social Medicine Chair, Pomeranian Medical University in Szczecin, Faculty of Health Sciences, Szczecin, Poland.

Artur Kotwas (A)

Department of Public Health, Pomeranian Medical University, Faculty of Health Sciences, Szczecin, Poland.

Marcin Korzeń (M)

Department of Methods of Artificial Intelligence and Applied Mathematics, West Pomeranian University of Technology, Szczecin, Poland.

Bartosz Rudnicki (B)

Healthcare Management and Administration, Faculty of Health Sciences, Pomeranian Medical University, Szczecin, Poland.

Tomasz Nogal (T)

Healthcare Management and Administration, Faculty of Health Sciences, Pomeranian Medical University, Szczecin, Poland.

Catalina Liliana Andrei (CL)

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Marcel Ausloos (M)

School of Business, University of Leicester, Leicester, England, United Kingdom.
Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania.

Maciej Banach (M)

Department of Hypertension, Medical University of Lodz, Lodz, Poland.
Mothers' Memorial Hospital Research Institute, Lodz, Poland.

Alexandra Brazinova (A)

Institute of Epidemiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.

Maria-Magdalena Constantin (MM)

IInd Department of Dermatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
IInd Department of Dermatology, Colentina Clinical Hospital, Bucharest, Romania.

Eleonora Dubljanin (E)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Claudiu Herteliu (C)

Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania.

Mihaela Hostiuc (M)

Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Department of Internal Medicine, Bucharest Emergency Hospital, Bucharest, Romania.

Sorin Hostiuc (S)

Department of Legal Medicine and Bioethics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Department of Clinical Legal Medicine, National Institute of Legal Medicine Mina Minovici, Bucharest, Romania.

Mihajlo Jakovljevic (M)

N.A. Semashko Department of Public Health and Healthcare, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Jacek Jerzy Jozwiak (JJ)

Department of Family Medicine and Public Health, University of Opole, Opole, Poland.
Faculty of Medicine and Health Sciences, University of Opole, Opole, Poland.

Katarzyna Kissimova-Skarbek (K)

Department of Health Economics and Social Security, Jagiellonian University Medical College, Krakow, Poland.

Zbigniew J Król (ZJ)

Data and Analyses Department, Ministry of Health, Warsaw, Poland.

Tomislav Mestrovic (T)

Clinical Microbiology and Parasitology Unit, Dr. Zora Profozic Polyclinic, Zagreb, Croatia.
University Centre Varazdin, University North, Varazdin, Croatia.

Bartosz Miazgowski (B)

Center for Innovation in Medical Education, Pomeranian Medical University, Szczecin, Poland.

Neda Milevska Kostova (N)

Department of Health Policy and Management, Centre for Regional Policy Research and Cooperation 'Studiorum', Skopje, Macedonia.

Mohsen Naghavi (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States of America.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, United States of America.

Ionut Negoi (I)

Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
General Surgery Department, Emergency Hospital of Bucharest, Bucharest, Romania.

Ruxandra Irina Negoi (RI)

Anatomy and Embryology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Department of Cardiology, Cardio-Aid, Bucharest, Romania.

Adrian Pana (A)

Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania.
Department of Health Outcomes, Center for Health Outcomes & Evaluation, Bucharest, Romania.

Salvatore Rubino (S)

Department of Biomedical Sciences, Università degli Studi di Sassari, Sassari, Italy.

Mario Sekerija (M)

Department of Medical Statistics, Epidemiology and Medical Informatics, School of Medicine, University of Zagreb, Zagreb, Croatia.
Croatian Institute of Public Health, Zagreb, Croatia.

Radoslaw Sierpinski (R)

Polish Medical Research Agency, Warsaw, Poland.
Department of Arrhythmias, Cardinal Wyszynski National Institute of Cardiology, Warsaw, Poland.

Lucjan Szponar (L)

National Food and Nutrition Institute, Warsaw, Poland.

Roman Topor-Madry (R)

Institute of Public Health, Jagiellonian University Medical College, Krakow, Poland.
Agency for Health Technology Assessment and Tariff System, Warsaw, Poland.

Isidora S Vujcic (IS)

Institute of Epidemiology, University of Belgrade, Belgrade, Serbia.

Justyna Widecka (J)

Zdroje Hospital, Pomeranian Medical University, Szczecin, Poland.

Katarzyna Widecka (K)

Cardiology Clinic, Pomeranian Medical University, Szczecin, Poland.

Bogdan Wojtyniak (B)

Department of Population Health Monitoring and Analysis, National Institute of Public Health, Warsaw, Poland.

Vesna Zadnik (V)

Epidemiology and Cancer Registry Sector, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Jacek A Kopec (JA)

University of British Columbia, Vancouver, BC, Canada.
Arthritis Research Canada, Richmond, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH